CIK 0001672688 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Absci Corp
Sign in to watch- Ticker
- ABSI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 853383487
- Phone
- (360) 949-1041
- Business address
- 18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683
- Former names
- AbSci, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 40 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-12 | MCGINNIS KAREN K Director | Grant or award · Stock Option (right to buy) | +36,274 | 36,274 | ||
| 2024-06-12 | VAN HOUTEN FRANS Director | Grant or award | +8,820 | 8,820 | ||
| 2024-06-12 | VAN HOUTEN FRANS Director | Grant or award · Stock Option (right to buy) | +36,274 | 36,274 | ||
| 2024-06-12 | Nagpal Amrit Director | Grant or award | +8,820 | 8,820 | ||
| 2024-06-12 | Nagpal Amrit Director | Grant or award · Stock Option (Right to Buy) | +36,274 | 36,274 | ||
| 2024-06-12 | Redmile Group, LLC Director | Grant or award | +8,820 | 8,262,136 | ||
| 2024-06-12 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +36,274 | 36,274 | ||
| 2024-05-22 | Phoenix Venture Partners II LP 10% owner | Sale | −3,100,000 | $4.40 | $13.6M | 11,279,522 |
| 2024-03-19 | McClain Sean Chief Executive Officer | Grant or award | +1,500,000 | 8,225,955 | ||
| 2024-03-01 | Redmile Group, LLC Director | Purchase | +222,222 | $4.50 | $1000K | 8,253,316 |
| 2024-02-01 | Bedrick Todd SVP, CAO | Grant or award | +20,570 | 154,670 | ||
| 2024-02-01 | Bedrick Todd SVP, CAO | Grant or award · Stock Option (right to buy) | +86,790 | 86,790 | ||
| 2024-02-01 | Busch Andreas Chief Innovation Officer | Grant or award | +83,125 | 258,125 | ||
| 2024-02-01 | Busch Andreas Chief Innovation Officer | Grant or award · Stock Option (right to buy) | +349,625 | 349,625 | ||
| 2024-02-01 | Jonasson Zachariah CFO / CBO | Grant or award | +114,010 | 375,910 | ||
| 2024-02-01 | Jonasson Zachariah CFO / CBO | Grant or award · Stock Option (right to buy) | +479,570 | 479,570 | ||
| 2024-02-01 | McClain Sean Chief Executive Officer | Grant or award | +182,000 | 6,725,955 | ||
| 2024-02-01 | McClain Sean Chief Executive Officer | Grant or award · Stock Option (right to buy) | +766,000 | 766,000 | ||
| 2024-01-02 | Pangalos Menelas N Director | Grant or award · Stock Option (right to buy) | +106,200 | 106,200 | ||
| 2024-01-02 | Pangalos Menelas N Director | Grant or award · Stock Option (right to buy) | +18,900 | 18,900 |
Page 7 of 8 · 154 trades